BRPI0519710A2 - tricyclic amino alcohols, process for their preparation and use as an anti-inflammatory - Google Patents

tricyclic amino alcohols, process for their preparation and use as an anti-inflammatory

Info

Publication number
BRPI0519710A2
BRPI0519710A2 BRPI0519710-4A BRPI0519710A BRPI0519710A2 BR PI0519710 A2 BRPI0519710 A2 BR PI0519710A2 BR PI0519710 A BRPI0519710 A BR PI0519710A BR PI0519710 A2 BRPI0519710 A2 BR PI0519710A2
Authority
BR
Brazil
Prior art keywords
inflammatory
preparation
amino alcohols
tricyclic amino
tricyclic
Prior art date
Application number
BRPI0519710-4A
Other languages
Portuguese (pt)
Inventor
Markus Berger
Norbert Schmees
Heike Schaecke
Stefan Baeurle
Hartmut Rehwinkel
Anne Mengel
Konrad Krolikiewicz
Danja Grossbach
David Voigtlaender
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0519710A2 publication Critical patent/BRPI0519710A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

AMINOÁL-COOIS TRICÍCLICOS, PROCESSO PARA SUA PREPARAÇçO E SEU EMPREGO COMO ANTI-INFLAMATàRIO. A invenção refere-se a amino álcoois tricíclicos de fórmula geral ao processo para sua preparação e seu emprego como anti-inflamatório.TRICYCLIC AMINOALOCOLES, PROCESS FOR YOUR PREPARATION AND YOUR EMPLOYMENT AS ANTI-INFLAMMATORY. The invention relates to amino tricyclic alcohols of general formula to the process for their preparation and use as an anti-inflammatory.

BRPI0519710-4A 2004-12-22 2005-12-20 tricyclic amino alcohols, process for their preparation and use as an anti-inflammatory BRPI0519710A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063227A DE102004063227A1 (en) 2004-12-22 2004-12-22 Tricylic amino alcohols, process for their preparation and their use as anti-inflammatory agents
PCT/EP2005/013943 WO2006066950A2 (en) 2004-12-22 2005-12-20 Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
BRPI0519710A2 true BRPI0519710A2 (en) 2009-03-10

Family

ID=36250953

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519710-4A BRPI0519710A2 (en) 2004-12-22 2005-12-20 tricyclic amino alcohols, process for their preparation and use as an anti-inflammatory

Country Status (14)

Country Link
JP (1) JP2008524300A (en)
KR (1) KR20070089948A (en)
CN (1) CN101087780A (en)
AR (1) AR055016A1 (en)
AU (1) AU2005318354A1 (en)
BR (1) BRPI0519710A2 (en)
CA (1) CA2586973A1 (en)
DE (1) DE102004063227A1 (en)
GT (1) GT200500385A (en)
IL (1) IL183060A0 (en)
MX (1) MX2007007420A (en)
PA (1) PA8657801A1 (en)
PE (1) PE20061197A1 (en)
WO (1) WO2006066950A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE502004002403D1 (en) 2003-10-08 2007-02-01 Schering Ag TETRAHYDRONAPHTHALIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN INFLAMMATORY INHIBITION
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7402596B2 (en) 2005-03-24 2008-07-22 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
EP1834948A1 (en) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
TWI464148B (en) 2006-03-16 2014-12-11 Evotec Us Inc Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
EP1917963A1 (en) * 2006-10-31 2008-05-07 Bayer Schering Pharma Aktiengesellschaft Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
EP2072509A1 (en) 2007-12-18 2009-06-24 Bayer Schering Pharma Aktiengesellschaft 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents
WO2013119895A1 (en) 2012-02-08 2013-08-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
SG11201900687VA (en) 2016-07-29 2019-02-27 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
UA125519C2 (en) 2016-07-29 2022-04-13 Суновіон Фармасьютікалз Інк. Compounds and compositions and uses thereof
CA3070993A1 (en) 2017-08-02 2019-02-07 Sunovion Pharmaceuticals Inc. Isochroman compounds and uses thereof
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
KR102462991B1 (en) * 2020-11-02 2022-11-04 한국해양과학기술원 Compound from a Antarctic-Derived Fungal Strains Acremonium sp. SF-7394 and Composition for Anti-Inflammation, Anticancer or Anti-Diabetes Comprising the Same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038639A1 (en) * 2000-07-28 2002-02-21 Schering Ag New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism
US6903215B2 (en) * 2002-03-26 2005-06-07 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE10215316C1 (en) * 2002-04-02 2003-12-18 Schering Ag Quinoline and isoquinoline derivatives, a pharmaceutical agent and their use as anti-inflammatory agents
DE502004002403D1 (en) * 2003-10-08 2007-02-01 Schering Ag TETRAHYDRONAPHTHALIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN INFLAMMATORY INHIBITION
GB0418045D0 (en) * 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
DE102004044680B3 (en) * 2004-09-09 2006-06-08 Schering Ag Alkylidene tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2006066950A2 (en) 2006-06-29
GT200500385A (en) 2006-08-03
DE102004063227A1 (en) 2006-07-06
CA2586973A1 (en) 2006-06-29
MX2007007420A (en) 2007-07-17
WO2006066950A3 (en) 2006-08-17
KR20070089948A (en) 2007-09-04
AR055016A1 (en) 2007-08-01
PA8657801A1 (en) 2006-12-07
AU2005318354A1 (en) 2006-06-29
IL183060A0 (en) 2007-09-20
PE20061197A1 (en) 2006-12-07
JP2008524300A (en) 2008-07-10
CN101087780A (en) 2007-12-12

Similar Documents

Publication Publication Date Title
BRPI0519710A2 (en) tricyclic amino alcohols, process for their preparation and use as an anti-inflammatory
BRPI0408347B8 (en) pyrimidine derivatives, their use, and pharmaceutical composition and combination
PA8660301A1 (en) PIRAZOLO PIRIDINAS REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE
CR10157A (en) CHEMICAL COMPOUNDS
ECSP077271A (en) PIRIMIDINE DERIVATIVES
ECSP099044A (en) FUSIONED PYRIMID COMPOUNDS
PA8671301A1 (en) REPLACED PIRROLOPIRIDINS, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCESS
ECSP077259A (en) PIRIMIDINE DERIVATIVES
NI201000028A (en) HUMANIZED ANTI-CXCR5 ANTIBODIES, DERIVED THEREOF, AND THEIR USE.
UY30057A1 (en) PYRIMIDINES REPLACED WITH SULFOXIMINES, PROCESSES FOR THEIR PRODUCTION AND USE OF THE SAME AS DRUGS
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
HN2006029142A (en) PROCESS
BRPI0408561A (en) Methods for Manufacturing 2'-Deoxy-59-1-Nucleosides
BRPI0415203A (en) restructured pentanols, a process for their production and use as anti-inflammatory agents
HN2008000088A (en) HETEROCICLICOS OF 1,4-DIHIDROPIRIDINA- FUSIONADA, PROCESSES TO PREPARE THE SAME, ITS USE AND THE COMPOSITIONS THAT CONTAIN THEM.
CU20090009A7 (en) BENCILAMINS, A PROCESS FOR ITS PRODUCTION AND ITS USE AS ANTI-INFLAMMATORY AGENTS
BRPI0515186A (en) alkylidene-tetrahydronaphthalene derivatives, process for their production and use as an anti-inflammatory
DOP2006000024A (en) THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
SV2006002384A (en) PIRAZOLO PIRIDINAS REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE
PA8624401A1 (en) PROCESSES FOR THE PREPARATION OF HALURES OF ARIL- AND HETEROARIL-ALQUILSULFONILO
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
CR9208A (en) Processes for the preparation of aminoethoxybenzyl alcohols
ECSP088472A (en) DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCESSES FOR ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
GT200600048A (en) PIRROLES REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCESS.
UY29308A1 (en) DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]